138 related articles for article (PubMed ID: 8663052)
1. Proposed ligand binding site of the transmembrane receptor for neurotensin(8-13).
Pang YP; Cusack B; Groshan K; Richelson E
J Biol Chem; 1996 Jun; 271(25):15060-8. PubMed ID: 8663052
[TBL] [Abstract][Full Text] [Related]
2. Chimeric rat/human neurotensin receptors localize a region of the receptor sensitive to binding of a novel, species-specific, picomolar affinity peptide.
Cusack B; Groshan K; McCormick DJ; Pang YP; Perry R; Phung CT; Souder T; Richelson E
J Biol Chem; 1996 Jun; 271(25):15054-9. PubMed ID: 8662846
[TBL] [Abstract][Full Text] [Related]
3. Topography of the neurotensin (NT)(8-9) binding site of human NT receptor-1 probed with NT(8-13) analogs.
Lundquist JT; Büllesbach EE; Golden PL; Dix TA
J Pept Res; 2002 Feb; 59(2):55-61. PubMed ID: 11906607
[TBL] [Abstract][Full Text] [Related]
4. A single amino acid of the human and rat neurotensin receptors (subtype 1) determining the pharmacological profile of a species-selective neurotensin agonist.
Cusack B; Jansen K; McCormick DJ; Chou T; Pang Y; Richelson E
Biochem Pharmacol; 2000 Sep; 60(6):793-801. PubMed ID: 10930533
[TBL] [Abstract][Full Text] [Related]
5. Identification in the rat neurotensin receptor of amino-acid residues critical for the binding of neurotensin.
Botto JM; Chabry J; Nouel D; Paquet M; Séguéla P; Vincent JP; Beaudet A; Mazella J
Brain Res Mol Brain Res; 1997 Jun; 46(1-2):311-7. PubMed ID: 9191107
[TBL] [Abstract][Full Text] [Related]
6. Novel insights into GPCR-peptide interactions: mutations in extracellular loop 1, ligand backbone methylations and molecular modeling of neurotensin receptor 1.
Härterich S; Koschatzky S; Einsiedel J; Gmeiner P
Bioorg Med Chem; 2008 Oct; 16(20):9359-68. PubMed ID: 18809332
[TBL] [Abstract][Full Text] [Related]
7. Intermolecular interactions between the neurotensin and the third extracellular loop of human neurotensin 1 receptor.
Da Costa G; Bondon A; Coutant J; Curmi P; Monti JP
J Biomol Struct Dyn; 2013 Dec; 31(12):1381-92. PubMed ID: 23140271
[TBL] [Abstract][Full Text] [Related]
8. Identification of residues involved in neurotensin binding and modeling of the agonist binding site in neurotensin receptor 1.
Barroso S; Richard F; Nicolas-Ethève D; Reversat JL; Bernassau JM; Kitabgi P; Labbé-Jullié C
J Biol Chem; 2000 Jan; 275(1):328-36. PubMed ID: 10617622
[TBL] [Abstract][Full Text] [Related]
9. Interaction of the COOH-terminal domain of the neurotensin receptor with a G protein does not control the phospholipase C activation but is involved in the agonist-induced internalization.
Hermans E; Octave JN; Maloteaux JM
Mol Pharmacol; 1996 Feb; 49(2):365-72. PubMed ID: 8632771
[TBL] [Abstract][Full Text] [Related]
10. Identification and functional characterization of a 5-transmembrane domain variant isoform of the NTS2 neurotensin receptor in rat central nervous system.
Perron A; Sarret P; Gendron L; Stroh T; Beaudet A
J Biol Chem; 2005 Mar; 280(11):10219-27. PubMed ID: 15637074
[TBL] [Abstract][Full Text] [Related]
11. Deletion mutation in the putative third intracellular loop of the rat neurotensin receptor abolishes polyphosphoinositide hydrolysis but not cyclic AMP formation in CHO-K1 cells.
Yamada M; Yamada M; Watson MA; Richelson E
Mol Pharmacol; 1994 Sep; 46(3):470-6. PubMed ID: 7935327
[TBL] [Abstract][Full Text] [Related]
12. Probing the environment of neurotensin whilst bound to the neurotensin receptor by solid state NMR.
Williamson PT; Bains S; Chung C; Cooke R; Watts A
FEBS Lett; 2002 May; 518(1-3):111-5. PubMed ID: 11997028
[TBL] [Abstract][Full Text] [Related]
13. Mutagenesis and modeling of the neurotensin receptor NTR1. Identification of residues that are critical for binding SR 48692, a nonpeptide neurotensin antagonist.
Labbé-Jullié C; Barroso S; Nicolas-Etève D; Reversat JL; Botto JM; Mazella J; Bernassau JM; Kitabgi P
J Biol Chem; 1998 Jun; 273(26):16351-7. PubMed ID: 9632698
[TBL] [Abstract][Full Text] [Related]
14. Degradation of neurotensin by rat brain synaptic membranes: involvement of a thermolysin-like metalloendopeptidase (enkephalinase), angiotensin-converting enzyme, and other unidentified peptidases.
Checler F; Vincent JP; Kitabgi P
J Neurochem; 1983 Aug; 41(2):375-84. PubMed ID: 6308159
[TBL] [Abstract][Full Text] [Related]
15. Recycling ability of the mouse and the human neurotensin type 2 receptors depends on a single tyrosine residue.
Martin S; Vincent JP; Mazella J
J Cell Sci; 2002 Jan; 115(Pt 1):165-73. PubMed ID: 11801734
[TBL] [Abstract][Full Text] [Related]
16. Structure-based exploration of an allosteric binding pocket in the NTS1 receptor using bitopic NT(8-13) derivatives and molecular dynamics simulations.
Kling RC; Burchardt C; Einsiedel J; Hübner H; Gmeiner P
J Mol Model; 2019 Jun; 25(7):193. PubMed ID: 31209646
[TBL] [Abstract][Full Text] [Related]
17. High-affinity receptor sites and rapid proteolytic inactivation of neurotensin in primary cultured neurons.
Checler F; Mazella J; Kitabgi P; Vincent JP
J Neurochem; 1986 Dec; 47(6):1742-8. PubMed ID: 3021902
[TBL] [Abstract][Full Text] [Related]
18. A disulfide bonding interaction role for cysteines in the extracellular domain of the thyrotropin-releasing hormone receptor.
Cook JV; McGregor A; Lee T; Milligan G; Eidne KA
Endocrinology; 1996 Jul; 137(7):2851-8. PubMed ID: 8770906
[TBL] [Abstract][Full Text] [Related]
19. Immunological recognition of different forms of the neurotensin receptor in transfected cells and rat brain.
Boudin H; Grauz-Guyon A; Faure MP; Forgez P; Lhiaubet AM; Dennis M; Beaudet A; Rostene W; Pelaprat D
Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):277-83. PubMed ID: 7826341
[TBL] [Abstract][Full Text] [Related]
20. Analysis of binding sites and efficacy of a species-specific peptide at rat and human neurotensin receptors.
Cusack B; Chou T; Jansen K; McCormick DJ; Richelson E
J Pept Res; 2000 Jan; 55(1):72-80. PubMed ID: 10667863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
